NCT05191498View on ClinicalTrials.gov

Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

February 18, 2024

Study Completion Date

February 18, 2024

Conditions
Pancreas Cancer
Interventions
DEVICE

QuiremSpheres®

Intratumoral injection of QuiremSpheres® up to a dose of 150 Gy.

Trial Locations (1)

6525GA

Radboud University Medical Centre, Nijmegen

All Listed Sponsors
collaborator

Quirem Medical B.V.

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT05191498 - Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer | Biotech Hunter | Biotech Hunter